Hormonal contraception and pelvic inflammatory disease

European Journal of Contraception and Reproductive Health Care

Volumn 2, Issue 4, 1997, Pages 263-267

  Henry Suchet, J ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Chlamydia trachomatis infection; Hormonal contraception; Infertility prevention; Laparoscopy; Pelvic inflammatory disease; Sexually transmitted disease screening

Indexed keywords

ANTIINFECTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

ACUTE DISEASE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHRONIC DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; FAMILY PLANNING; FEMALE; HUMAN; MASS SCREENING; METHODOLOGY; PELVIC INFLAMMATORY DISEASE; PREVALENCE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHRONIC DISEASE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; COST-BENEFIT ANALYSIS; FAMILY PLANNING SERVICES; FEMALE; HUMANS; MASS SCREENING; PELVIC INFLAMMATORY DISEASE; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0031310734     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189709165305     Document Type: Article

References (28)

1. Henry-Suchet J, Tort-Grumbach J. Conduite àtenir devant une infection aiguë gynécologique. Encycl Med Chir Paris urgences 1984; 24206(A30): 1-8
2. Sweet RL, Mills J, Hadley KW, et al. Use of laparoscopy to determine the microbiologie etiology of acute salpingitis. Am J Obstet Gynecol 1979; 134: 68-74
3. Shafer MA, Pessione F, Scieux C, et al. C. trachoniatis: facteurs de risque chez les femmes de la région parisienne. Importance du tabagisme et de l'ectropion cervical. J Gynecol Obstet Biol Reprod 1993; 22: 163-8
4. Sluzhinska A, Scieux C, Bruna N, et al. Urine CT Screening in a Family Planning Center Paris. In Stary A, ed. Proceedings of the 3rd Meeting of the European Society of Chlamydia .Research.Vienna:Esculapio Bologna, 1996: 390
5. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, et al. Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol 1995; 173: 534-43
6. Mahmoud EA, Hamad EE, Olsson SE, et al. Antichlamydial activity of cervical secretion in different phases of the menstrual cycle and influence of hormonal contraceptives. Contraception 1994; 49: 265-74
7. Spinillo A, Gorini G, Piazzi G, et al. The impact of oral contraception on chlamydial infection among patients with pelvic inflammatory disease. Contraception 1996; 54: 163-8
8. Ness RB, Keder LM, Soper DE, et al. Oral contraception and the recognition of endometritis Am J Obstet Gynecol 1997; 176: 580-5
9. Cramer DW, Goldman MB, Schiff I, et al. The relationship of tubal infertility to barrier method and oral contraceptive use. J Am Med Assoc 1987; 257: 244-650
10. Gump DW, Gibson M, Ashikaga T. Evidence of prior pelvic inflammatory disease and its relationship to CT antibody and IUCD use in infertile women.Am J Obstet Gynecol 1983; 142: 153-9
11. Henry-Suchet J, Askienazy-Elbhar M, Orfila J. Clinical consequences of immune response to CT upper genital tract infection in women. Infect Dis Obstet Gynecol 1996; 4: 171-5
12. Henry-Suchet J, Revol C, Askienazy-Elbhar M, et al. Post-therapeutic evolution of serum chlamydial antibody titers in women with acute salpingitis and tubal infertility. Fertil Steril 1994; 62: 296-304
13. Stamm WA, Peeling RW, Money D, et al. Prevalence and correlates of antibody to Chlamydial HSP-60 in C. trachomatis infected women. In Orfila J, ed. Proceedings of 8th International Symposium on Human Chlamydial Infection. Vienna: Esculapio Bologna 1994; 614-17
14. Henry-Suchet J. Laparoscopic treatment of tubo-ovarian abscesses. J Obstet Gynecol 1986; 6(Suppl 1): S60-1
15. Sweet R. Pelvic inflammatory disease. Hosp Prac 1993; 28: 25-30
16. Henry-Suchet J, Dahan M, Tannous W, et al. Salpingites aiguës non spécifiques. Conduite à tenir. Ed Tech-Encycl Méd Chir Paris-Franc 1995; 470(No A10): 1-18
17. Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975; 121: 707-13
18. Westrom L. Consequences of gential chlamydial infections in women. In Stary A, ed. Proc Eur Soc Chlamydia Res 1996; 3: 137-40
19. Bassil S, Le Bouedec G, Mage G, et al. Place des antiinflammatoires dans le traitement des salpingites aiguës. J Gynecol Obstet Biol Reprod 1991; 20: 1063-7
20. Henry-Suchet J, Catalan F, Loffredo V, et al. Microbiology of specimens obtained by laparoscopy from controls and from patients with pelvic inflammatory disease or infertility with tubal obstruction. Am J Obstet Gynecol 1980; 138: 1022-5
21. Henry-Suchet J, Sluzhinska A, Serfaty D. Chlamydia trachomatis screening in family planning centres. A review of cost/benefit evaluations in different countries. Eur J Contracept Reprod Health Care 1996; 1: 301-9
22. Mårdh PA, Creatsas G, Guaschino S, et al. Is Europe ready to screen women for genital chlamydial infections? Study in Family Planning Centres in 14 European countries. In Stary A, ed. Proc Eur Soc Chlamydia Res 1996; 3: 381-3
23. Blackwell AL, Thomas PD, Wareham K, et al. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy, Lancet 1993; 342: 206-9
24. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334: 1362-6
25. Stray-Pedersen B. Prévention des MST. L'expérience Norvégienne. Contracept Fertil Sex 1996; 24: 213-7
26. Addis DG, Vaughn ML, Ludka D, et al. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in FPC in Wisconsin. Sex Transm Dis 1993; 20: 28-35
27. Gene M, Mårdh PA. Cost effectiveness analysis of screening and treatment for C. trachomatis infection in asymptomatic women. Ann Intern Med 1996; 124: 1-7
28. Hammerschlag MR, Golden NH, Oh MK, et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. J Pediatr 1993; 122: 961-5